Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

301 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The 17-gene stemness score associates with relapse risk and long-term outcomes following allogeneic haematopoietic cell transplantation in acute myeloid leukaemia.
Kim DDH, Novitzky Basso I, Kim TS, Yi SY, Kim KH, Murphy T, Chan S, Minden M, Pasic I, Lam W, Law A, Michelis FV, Gerbitz A, Viswabandya A, Lipton J, Kumar R, Ng SWK, Stockley T, Zhang T, King I, Mattsson J, Wang JCY. Kim DDH, et al. Among authors: yi sy. EJHaem. 2022 May 23;3(3):873-884. doi: 10.1002/jha2.466. eCollection 2022 Aug. EJHaem. 2022. PMID: 36051057 Free PMC article.
Can upfront systemic chemotherapy replace stereotactic radiosurgery or whole brain radiotherapy in the treatment of non-small cell lung cancer patients with asymptomatic brain metastases?
Kim KH, Lee J, Lee JI, Nam DH, Kong DS, Ahn YC, Park HC, Kwon OJ, Kim H, Chang MH, Yi SY, Ji SH, Park YH, Ahn JS, Park K, Ahn MJ. Kim KH, et al. Among authors: yi sy. Lung Cancer. 2010 May;68(2):258-63. doi: 10.1016/j.lungcan.2009.06.008. Epub 2009 Jul 9. Lung Cancer. 2010. PMID: 19592127
Allogeneic transplant can abrogate the risk of relapse in the patients of first remission acute myeloid leukemia with detectable measurable residual disease by next-generation sequencing.
Ahn JS, Kim T, Jung SH, Ahn SY, Jung SY, Song GY, Kim M, Yang DH, Lee JJ, Choi S, Lee JY, Park SK, Moon JH, Lee HY, Kim KH, Cai Y, Yi SY, Novitzky-Basso I, Zhang Z, Kim HJ, Kim DDH. Ahn JS, et al. Among authors: yi sy. Bone Marrow Transplant. 2021 May;56(5):1159-1170. doi: 10.1038/s41409-020-01165-x. Epub 2020 Dec 5. Bone Marrow Transplant. 2021. PMID: 33279940
Irinotecan monotherapy as second-line treatment in advanced pancreatic cancer.
Yi SY, Park YS, Kim HS, Jun HJ, Kim KH, Chang MH, Park MJ, Uhm JE, Lee J, Park SH, Park JO, Lee JK, Lee KT, Lim HY, Kang WK. Yi SY, et al. Cancer Chemother Pharmacol. 2009 May;63(6):1141-5. doi: 10.1007/s00280-008-0839-y. Epub 2008 Oct 7. Cancer Chemother Pharmacol. 2009. PMID: 18839175 Clinical Trial.
A phase I/II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer.
Kim KH, Park YS, Chang MH, Kim HS, Jun HJ, Uhm J, Yi SY, Lim DH, Ji SH, Park MJ, Lee J, Park SH, Park JO, Lim HY, Kang WK. Kim KH, et al. Among authors: yi sy. Cancer Chemother Pharmacol. 2009 Jul;64(2):347-53. doi: 10.1007/s00280-008-0878-4. Epub 2008 Dec 6. Cancer Chemother Pharmacol. 2009. PMID: 19066894 Clinical Trial.
301 results